Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • 16 Generation Now

    June 5, 2017 | Development, Digital, HCP, Healthcare professionals, Innovation, Millennial, creativity, doctors, technology 

    The impact of the millennial healthcare professional on our world

    We believe that pharma companies have a choice
    to make: they can either be commodity-based manufacturers of pills, or they can be partners to patients and physicians in the design of better treatment journeys. And, in the age of the socially conscious, there is only one choice for sustainable success.

    Healthcare is in an age of transformation, with new science, new technology, new funding models and newly empowered patients. But at the heart of this transformation will be the millennial healthcare professionals (mHCPs). They exhibit different behaviours, different triggers and different ambitions, which must be understood by pharma if the true benefits of their progress are to be realised.

    In this paper we will discuss the changes in society that are transforming physicians, and how we as an industry can best evolve to support stakeholders, improve outcomes and build brands.

    This paper draws on in-depth interviews conducted by Havas Lynx with leading mHCPs, as well as with medical students, academics, technologists, prosumer patients and entrepreneurs from around the world, including the EU, North America and Asia.

    This content was provided by Havas Lynx

    Documents for download:

    Company Details

    - PMLiVE

    Havas Lynx

    Email
    Website

     Latest Content from  Havas Lynx 

    Doctored Truths urges pharma to lead the fight against health misinformation

    “Doctored Truths” exposes the escalating crisis of health misinformation and disinformation, which has been ranked the world’s top short-term risk to the world, for the second year in a row....

    Havas Lynx Welcomes New Leadership Hires

    Havas Lynx announces the appointment of Ayesha Walawalkar as Chief Strategy Officer, and Talin Apkarian as Havas Lynx Hudson Managing Director.

    Havas to Open New Manchester Village at Circle Square

    The global communications group will unite six agencies under one roof in a purpose-built, hybrid workspace at the heart of Manchester’s innovation district

    Havas Lynx launches proprietary data product to drive meaningful change across pharma

    Leading global healthcare communications agency, Havas Lynx , has launched its proprietary data platform, Point.1, to help pharmaceutical companies to gain a deeper understanding of healthcare professionals (HCPs) to drive...

    Healing the Healers

    Because if we do not heal the healers, who is going to heal us?

    THE HIDDEN LIFESAVERS: overdose prevention campaign launches nationwide

    The campaign encourages people who use drugs to do something remarkable – save a life

    Andi Goes – the children’s book that helps detect early signs of dyslexia

    Havas Lynx Group have launched a children’s book aimed at raising awareness and detecting early signs of dyslexia. Helping to make sure that parents have the support they need whilst...

    Neurofibromatosis: a condition that’s hard to say, but even harder to live with

    The Childhood Tumour Trust and Havas Lynx Group have launched a campaign to raise awareness and funds for people living with a rare genetic condition, neurofibromatosis 1 (NF1).

    Havas Health & You Launches Behind the Mask, a Global Research Initiative to Document Health Experiences During the COVID-19 Pandemic and Beyond

    Havas Health & You (HH&Y) have launched the details of a long-term global research project, Behind the Mask, a longitudinal, multi-armed study which focuses on documenting the ongoing evolution of...

    Media Means Business

    Creating meaningful media experiences in pharma